Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-26-000173
Filing Date
2026-05-05
Accepted
2026-05-05 16:08:44
Documents
86
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20260331.htm   iXBRL 10-Q 1872147
2 EX-31.1 a2026q110-qexhibit311.htm EX-31.1 10575
3 EX-31.2 a2026q110-qexhibit312.htm EX-31.2 10589
4 EX-32.1 a2026q110-qexhibit321.htm EX-32.1 6248
10 GRAPHIC vrtx-20260331_g1.gif GRAPHIC 30799
11 GRAPHIC vrtx-20260331_g2.gif GRAPHIC 20431
  Complete submission text file 0000875320-26-000173.txt   9804761

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20260331.xsd EX-101.SCH 46569
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20260331_cal.xml EX-101.CAL 94057
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20260331_def.xml EX-101.DEF 278354
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20260331_lab.xml EX-101.LAB 623549
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20260331_pre.xml EX-101.PRE 475043
90 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20260331_htm.xml XML 1920482
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 26943114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)